Advertisement

Association Between Melatonin and Neuroimmune Diseases

  • Murat Terzi
  • Mehmet Emin Onger
  • Aysin Pınar Turkmen
  • Sefa Ersan Kaya
  • Arife Ahsen Kaplan
  • Berrin Zuhal Altunkaynak
  • Suleyman Kaplan
Chapter

Abstract

Pineal gland has been defined by Herophilus in the third century BC in 1958. Pineal gland is located in the central part of the brain at the roof of the third ventricle. It is surrounded by the pia mater. Despite its tiny size in proportion to the body, pineal gland is exposed to a high volume of blood flow. Pineal gland consists of pinealocytes and glial cells (Fig. 11.1).

Keywords

Multiple Sclerosis Experimental Autoimmune Encephalomyelitis Multiple Sclerosis Patient Pineal Gland Melatonin Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Arendt J. Melatonin, circadian rhythms and sleep. New Engl J Med. 2000;343:1114–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Bahamonde C, Conde C, Agüera E, Lillo R, Luque E, Gascón F, Feijóo M, Cruz AH, Sánchez-López FS, Túnez I. Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: relationship to oxidative stress. Eur J Pharmacol. 2014;730:26–30.CrossRefPubMedGoogle Scholar
  3. 3.
    Boivin DB. Influence of sleep-wake and circadian rhythms and the biology of mood disorders. Pharmacol Ther. 2007;114:222–32.CrossRefGoogle Scholar
  4. 4.
    Brennan CP, Hendricks GL, El-Sheikh TM, Mashaly MM. Melatonin and the enhancement of immune responses in immature male chickens. Poult Sci. 2002;81:371–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Brezezinski A. Melatonin in humans. N Engl J Med. 1997;336:186–95.CrossRefGoogle Scholar
  6. 6.
    Brzozowska I, Ptak-Belowska A, Pawlik M, Pajdo R, Drozdowicz D, Konturek SJ, Pawlik WW, Brzozowski T. Mucosal strengthening activity of central and peripheral melatonin in the mechanism of gastric defense. J Physiol Pharmacol. 2009;7:47–56.CrossRefGoogle Scholar
  7. 7.
    Checkley SA, Murphy DGM, Abbas M. Melatonin rhythms in seasonal affective disorder. Br J Psychiatry. 1993;163:332–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev. 2010;62:343–80.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine. 2005;27:101–10.CrossRefPubMedGoogle Scholar
  10. 10.
    Escames G, Guerrero JM, Reiter RJ. Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates. Neurosci Lett. 1997;230:147–50.CrossRefPubMedGoogle Scholar
  11. 11.
    Esquifino AI, Perumal SRP, Cardinali DP. Circadian organization of the immune response: a role for melatonin. Clin Appl Immunol Rev. 2004;4:423–33.CrossRefGoogle Scholar
  12. 12.
    Farhadi N, Oryan S, Nabiuni M. Serum levels of melatonin and cytokines in multiple sclerosis. Biomed J. 2014;37:90–2.CrossRefPubMedGoogle Scholar
  13. 13.
    Fourtillan JB, Brisson AM, Fourtillan M, Ingrand I, Decourt JP, Girault J. Melatonin secretion occurs at a constant rate in both young and older men and women. Am J Physiol Endocrinol Metabol. 2001;280:E11–22.Google Scholar
  14. 14.
    Garcia MS, Gonzalez HMG, Calvo JR, Rafii IM, Sanchez MV, Goberna R, Guerrero JM. Melatonin enhances IL-2, IL-6 and IFN gamma production by human circulating CD4+ cells: a possible nuclear receptor mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol. 1997;159:574–81.Google Scholar
  15. 15.
    Glenister R, McDaniel K, Francis H, Venter J, Jensen K, Dusio G, Gaudio E, Glaser S, Meng F, Alpini G. Therapeutic actions of melatonin on gastrointestinal cancer development and progression. Transl Gastrointest Cancer. 2013;2:11–20.PubMedCentralGoogle Scholar
  16. 16.
    Gómez BP, Reyes-Vázquez C, Velázquez-Paniagua M. Melatonin avoids anatomofunctional changes associated to aging in a rat model. Adv Aging Res. 2014;3:318–25.CrossRefGoogle Scholar
  17. 17.
    Hotchkiss AK, Nelson RJ. Melatonin and immune function: hype or hypothesis? Crit Rev Immunol. 2002;22:351–71.PubMedGoogle Scholar
  18. 18.
    Kashani IR, Rajabi Z, Akbari M, Hassanzadeh G, Mohseni A, Eramsadati MK, Rafiee K, Beyer C, Kipp M, Zendedel A. Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis. Exp Brain Res. 2014;232:2835–46.CrossRefPubMedGoogle Scholar
  19. 19.
    Kerman M, Cirak B, Özgüner MF. Does melatonin protect or treat brain damage from traumatic oxidative stress? Exp Brain Res. 2005;163:406–10.CrossRefPubMedGoogle Scholar
  20. 20.
    Konturek SJ, Konturek PC, Brzozowski T, Bubenik GA. Role of melatonin in upper gastrointestinal tract. J Physiol Pharmacol. 2007;58:23–52.PubMedGoogle Scholar
  21. 21.
    Kuklina EM. Melatonin as potential inducer of Th17 cell differentiation. Med Hypotheses. 2014;83:404–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Lam RW, Song C, Yatham LN. Does neuroimmune dysfunction mediate seasonal mood changes in winter depression? Med Hypotheses. 2004;63:567–73.CrossRefPubMedGoogle Scholar
  23. 23.
    Lin GJ, Huang SH, Chen SJ, Wang CH, Chang DM, Sytwu HK. Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases. Int J Mol Sci. 2013;14:11742–66.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Maestroni GJ. The immunoendocrine role of melatonin. J Pineal Res. 1993;14:1–10.CrossRefPubMedGoogle Scholar
  25. 25.
    Maestroni GJ. The photoperiod transducer melatonin and the immune-hematopoietic system. J Photochem Photobiol B. 1998;43:186–92.CrossRefPubMedGoogle Scholar
  26. 26.
    Maestroni GJ. The immunotherapeutic potential of melatonin. Expert Opin Investig Drugs. 2001;10:467–76.CrossRefPubMedGoogle Scholar
  27. 27.
    Ozcelik F, Erdem M, Bolu A, Gülsün M. Melatonin: general features and its role in psychiatric disorders. Curr Approaches Psychiatry. 2013;5:179–203.Google Scholar
  28. 28.
    Pieri C, Marra M, Moroni F. Impact of melatonin on immunity: a review. Cent Eur J Med. 2013;8:369–76.Google Scholar
  29. 29.
    Pioli C, Caroleo MC, Nistico G, Doria G. Melatonin increases antigen presentation and amplifies specific and non-specific signals for T cell proliferation. Int J Immunopharmacol. 1993;15:463–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Reiter RJ, Calvo JR, Karbownik M. Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci. 2000;917:376–86.CrossRefPubMedGoogle Scholar
  31. 31.
    Reiter RJ, Tan DX, Galano A. Melatonin: exceeding expectations. Physiology (Bethesda). 2014;29:325–33.Google Scholar
  32. 32.
    Sowa MA, Pierzchala K, Sowa P, Mucha S, Sadowska-Bartosz I, Adamczyk J, Hartel M. Melatonin acts as antioxidant and improves sleep in MS patients. Neurochem Res. 2014;39:1585–93.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Szczepanik M. Melatonin and its influence on immune system. J Physiol Pharmacol. 2007;58:115–24.PubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  • Murat Terzi
    • 1
  • Mehmet Emin Onger
    • 2
  • Aysin Pınar Turkmen
    • 2
  • Sefa Ersan Kaya
    • 2
  • Arife Ahsen Kaplan
    • 2
  • Berrin Zuhal Altunkaynak
    • 2
  • Suleyman Kaplan
    • 2
  1. 1.Departments of Neurology, Medical FacultyOndokuz Mayıs UniversitySamsunTurkey
  2. 2.Department of Histology and Embryology, Medical School, Medical FacultyOndokuz Mayıs UniversitySamsunTurkey

Personalised recommendations